Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Phase I Trial of ZEN003694 (ZEN-3694) in Combination with Capecitabine in Patients with Solid Tumors

Multiple Cancer Types

Imaging Biomarkers of Lymphatic Dysfunction

Breast

A Phase 2 Trial of Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome Undergoing Reduced Intensity or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation with Orca-T

Multiple Cancer Types

A Phase 1, Open-Label, Multicenter Study of INCB160058 in Participants with Myeloproliferative Neoplasms

Phase I/II Trial of Gabapentin plus Ketamine for Prevention and Treatment of Acute and Chronic Pain in Locally Advanced Head and Neck Cancer Patients Undergoing Primary or Adjuvant Chemoradiation.

Multiple Cancer Types

Phase I/II Study of the Safety, Tolerability and Efficacy of Belantamab Mafodotin (GSK2857916) in Combination with Iberdomide (CC-220)/Dexamethasone versus Belantamab Mafodotin (GSK2857916)/Dexamethasone in Relapsed Refractory Multiple Myeloma

A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of A2B694, an Autologous Logic-gated Tmod CAR T, in Heterozygous HLA-A*02 Adults with Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors that Express MSLN and Have Lost HLA-A*02 Expression

Miscellaneous

A Randomized, Double-blinded, Multicenter, Phase III Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) in Combination with Trastuzumab and Chemotherapy (XELOX) versus Trastuzumab and Chemotherapy (XELOX) with or without Pembrolizumab for the First Line Treatment of Locally Advanced or Metastatic Gastroesophageal Junction and Gastric Cancer

Multiple Cancer Types

A Randomized Phase 2 Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-Line Advanced Renal Cell Carcinoma (RCC)

Kidney (Renal Cell)

ALTE2131 Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults with Cancer an NCORP Phase 3 Study

Ovarian